A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial.
David G Armstrong, Dennis P Orgill, Robert D Galiano et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the efficacy of a novel composite CAMP, OFM-HA, in treating full thickness diabetic foot ulcers (DFUs) in 143 patients. The study found that 46% of patients receiving OFM-HA plus standard of care (SOC) healed by 12 weeks, compared to 24% in the SOC alone group (p = 0.008).
Key findings
- 46% of the OFM-HA plus SOC group healed by 12 weeks compared to 24% in the SOC alone group (p = 0.008).
- Kaplan-Meier analysis showed a significant advantage for OFM-HA plus SOC over 12 weeks (log-rank p = 0.023).
- No unexpected safety-related occurrences were observed during the trial.
Why it matters
Diabetic foot ulcers are a significant complication of diabetes, impacting patient quality of life and healthcare costs. This study suggests that advanced therapies like OFM-HA may improve healing outcomes in patients with chronic DFUs.
What to keep in mind
Interpretation is limited by post-randomization exclusions, differential withdrawal, and an adjusted comparison close to the significance threshold.